The innovative technology of Sinovation Medical originates from Tsinghua University. It has dedicated over two decades to continuous research and production of high-end neurosurgical medical devices. The birth of the Sinobot X1 has once again elevated the definition of neurosurgical robots to new heights. The integration of Holoshot? 3D structured light registration technology with fully automated robotic arms brings neurosurgeons an experience of utmost precision, convenience, and efficiency in surgical assistance. This advancement enables clinical procedures to constantly surpass and break through boundaries, turning them into reality.
The Sinobot X1 (aka SR1-3D) has obtained both the NMPA approval through the Special Channel for Innovative Medical Devices in China, and the US FDA approval.
In neurosurgical robot-assisted surgeries, patient registration is a crucial step throughout the entire surgical process. Its main purpose is to map the surgical path planned by the surgeon in the imaging space to the real-world space. The accuracy of patient registration directly determines the precision of the system's final navigation and localization. Additionally, the convenience of the patient registration process also directly affects the overall duration of the surgery.
The robotic arm is a core component of any surgical robot, and neurosurgery demands peak performance from this crucial component. As a pioneer in the medical robot industry, Sinovation always upholds strict standards regarding safety, developing products that enable safer and more accurate robotic surgeries for both doctors and patients alike.
The surgical planning system is the soul of any intelligent surgical robot. Over the last decade, Sinovation has meticulously developed SinoPlanTM, a robust and user-friendly surgical planning system tailored to the clinical needs of specialists. This system enables comprehensive, accurate and fast planning, coupled with simulated execution.
Through substantial technical expertise, a wealth of clinical experience and collaborative efforts with medical professionals, the Sinobot X1 excels in treating a wide variety of diseases such as intracranial tumor, cerebral hemorrhage, Parkinson's disease, trigeminal neuralgia, epilepsy, and more. Our robot’s open platform facilitates future expansion, ensuring its adaptability to evolving clinical needs.
